Hochschulschrift
Composite time-to-event endpoints in clinical and epidemiologic trials : evaluation of alternative analysis methods
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
v, 99 Blätter
- Language
-
Englisch
- Notes
-
Diagramme
Enthält Sonderabdrucke
Universität Hamburg, Dissertation, 2020
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:19 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2020
Other Objects (12)
Methods for planning and analyzing clinical trials with composite endpoints
Improving the analysis of composite endpoints in rare disease trials
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Mixed response and time-to-event endpoints for multistage single-arm phase II design
Endpoints for clinical trials in retinal diseases
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Methods for planning and analyzing clinical trials with composite endpoints
Improving the analysis of composite endpoints in rare disease trials
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Mixed response and time-to-event endpoints for multistage single-arm phase II design
Endpoints for clinical trials in retinal diseases
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Methods for planning and analyzing clinical trials with composite endpoints
Improving the analysis of composite endpoints in rare disease trials
Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints
The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
Imputation of Missing Data for Time-to-Event Endpoints Using Retrieved Dropouts
A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials
Mixed response and time-to-event endpoints for multistage single-arm phase II design
Endpoints for clinical trials in retinal diseases
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons
Efficacy Endpoints in Clinical Trials in Actinic Keratosis